barium sulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4346 7727-43-7

Description:

MoleculeDescription

Synonyms:

  • barium sulfate paste
  • barium sulfate
  • barium sulphate
A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
  • Molecular weight: 233.38
  • Formula: BaO4S
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 80.26
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
No adverse event 94.53 48.87 23 199 33555 50571347
Urticaria 52.66 48.87 20 202 129541 50475361

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
No adverse event 64.24 51.08 14 82 17464 29556967
Aspiration 59.55 51.08 12 84 10168 29564263

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Aspiration 74.02 38.71 17 300 16868 64481547
Urticaria 65.23 38.71 25 292 147292 64351123
Barium impaction 44.92 38.71 4 313 0 64498415

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V08BA01 VARIOUS
CONTRAST MEDIA
X-RAY CONTRAST MEDIA, NON-IODINATED
Barium sulfate containing X-ray contrast media
FDA MoA N0000010258 X-Ray Contrast Activity
MeSH PA D003287 Contrast Media
MeSH PA D064907 Diagnostic Uses of Chemicals
FDA EPC N0000180185 Radiographic Contrast Agent
CHEBI has role CHEBI:37338 contrast media

Drug Use (View source of the data)

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4018191 VUID
N0000146525 NUI
D02052 KEGG_DRUG
4018191 VANDF
C0004754 UMLSCUI
CHEBI:133326 CHEBI
CHEMBL2105897 ChEMBL_ID
D001466 MESH_DESCRIPTOR_UI
DB11150 DRUGBANK_ID
25BB7EKE2E UNII
24414 PUBCHEM_CID
1331 RXNORM
4245 MMSL
740 MMSL
d01445 MMSL
001100 NDDF
25419009 SNOMEDCT_US
396014007 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
E-Z-Disk HUMAN PRESCRIPTION DRUG LABEL 1 10361-778 TABLET 700 mg ORAL Unapproved drug other 17 sections
Varibar Thin Liquid HUMAN PRESCRIPTION DRUG LABEL 1 32909-105 POWDER, FOR SUSPENSION 0.81 g ORAL NDA 13 sections
Varibar Nectar HUMAN PRESCRIPTION DRUG LABEL 1 32909-115 SUSPENSION 400 mg ORAL NDA 14 sections
Varibar Nectar HUMAN PRESCRIPTION DRUG LABEL 1 32909-116 SUSPENSION 400 mg ORAL NDA 14 sections
Varibar Thin Honey HUMAN PRESCRIPTION DRUG LABEL 1 32909-121 SUSPENSION 400 mg ORAL NDA 14 sections
Varibar Honey HUMAN PRESCRIPTION DRUG LABEL 1 32909-122 SUSPENSION 400 mg ORAL NDA 14 sections
Varibar Pudding HUMAN PRESCRIPTION DRUG LABEL 1 32909-125 PASTE 400 mg ORAL NDA 22 sections
ENTERO Vu 24% HUMAN PRESCRIPTION DRUG LABEL 1 32909-145 SUSPENSION 240 mg ORAL NDA 20 sections
ENTERO Vu 24% HUMAN PRESCRIPTION DRUG LABEL 1 32909-146 SUSPENSION 240 mg ORAL NDA 20 sections
Liquid Polibar Plus HUMAN PRESCRIPTION DRUG LABEL 1 32909-167 SUSPENSION 1.05 g ORAL Unapproved drug other 19 sections
Liquid Polibar Plus HUMAN PRESCRIPTION DRUG LABEL 1 32909-168 SUSPENSION 1.05 g ORAL Unapproved drug other 19 sections
E-Z-Paque HUMAN PRESCRIPTION DRUG LABEL 1 32909-186 SUSPENSION 0.60 g ORAL NDA 14 sections
E-Z-Paque HUMAN PRESCRIPTION DRUG LABEL 1 32909-187 SUSPENSION 0.60 g ORAL NDA 14 sections
Readi-Cat 2 Berry Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-711 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 Banana Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-722 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 HUMAN PRESCRIPTION DRUG LABEL 1 32909-724 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 Berry Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-741 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 Banana Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-742 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 HUMAN PRESCRIPTION DRUG LABEL 1 32909-744 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 Creamy Vanilla Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-746 SUSPENSION 20 mg ORAL NDA 15 sections
Readi-Cat 2 Mochaccino Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-747 SUSPENSION 20 mg ORAL NDA 15 sections
E-Z-Paque HUMAN PRESCRIPTION DRUG LABEL 1 32909-750 POWDER, FOR SUSPENSION 960 mg ORAL NDA 14 sections
Readi-Cat 2 Creamy Vanilla Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-756 SUSPENSION 20 mg ORAL NDA 15 sections
E-Z-HD HUMAN PRESCRIPTION DRUG LABEL 1 32909-764 POWDER, FOR SUSPENSION 980 mg ORAL NDA 15 sections
E-Z-Paste HUMAN PRESCRIPTION DRUG LABEL 1 32909-770 CREAM 0.60 g ORAL Unapproved drug other 19 sections
Readi-Cat 2 Mochaccino Smoothie HUMAN PRESCRIPTION DRUG LABEL 1 32909-777 SUSPENSION 20 mg ORAL NDA 15 sections
Tagitol V HUMAN PRESCRIPTION DRUG LABEL 1 32909-814 SUSPENSION 400 mg ORAL NDA 23 sections
NeuLumEX HUMAN PRESCRIPTION DRUG LABEL 1 32909-926 SUSPENSION 1 mg ORAL Unapproved drug other 18 sections
NeuLumEX HUMAN PRESCRIPTION DRUG LABEL 1 32909-927 SUSPENSION 1 mg ORAL Unapproved drug other 18 sections
Vanilla SilQ HUMAN PRESCRIPTION DRUG LABEL 1 69307-1024 SUSPENSION 21 mg ORAL unapproved drug other 15 sections